Yan, H., Yu, K., Zhang, K., Liu, L., & Li, Y. (2017). Efficacy and safety of trastuzumab emtansine (T-DM1) in the treatment of HER2-positive metastatic breast cancer (MBC): A meta-analysis of randomized controlled trial. Oncotarget.
استشهاد بنمط شيكاغوYan, Hongjing, Kewei Yu, Kaile Zhang, Linxia Liu, و Yue Li. "Efficacy and Safety of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-positive Metastatic Breast Cancer (MBC): A Meta-analysis of Randomized Controlled Trial." Oncotarget 2017.
MLA استشهادYan, Hongjing, et al. "Efficacy and Safety of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-positive Metastatic Breast Cancer (MBC): A Meta-analysis of Randomized Controlled Trial." Oncotarget 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.